Tagbef 250mg Tablet: Effective Relief for Your Needs

Tagbef 250mg Tablet

Uses:

• Treatment of non-small cell lung cancer (NSCLC), particularly in patients where the cancer has spread and who have certain types of abnormal epidermal growth factor (EGFR) genes.

Therapeutic Effects:

• Contains Gefitinib, an anilinoquinazoline derivative that interacts with a kinase inhibitor to inhibit an abnormal protein called the epidermal growth factor receptor (EGFR).
• Helps to slow or stop the growth of cancer cells and reduce the size of tumors in patients with NSCLC.

Dosage and Administration:

• Prescribed by a healthcare professional.
• Available as a tablet to be taken with or without food, as directed by your healthcare provider.
• Usual recommended dosage is 250 mg tablet once daily.
• Swallow the tablet whole with a glass of water.
• Take at the same time every day.

Safety Advice:

• Pregnancy: unsafe to use during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during treatment.
• Breastfeeding: unsafe to breastfeed during treatment. Consult your doctor before breastfeeding.
• Lungs: consult your doctor if you have any lung diseases before starting treatment.
• Liver: consult your doctor if you have any liver problems before starting treatment.
• Alcohol: avoid consuming alcohol as it may cause dizziness.
• Driving: avoid driving vehicles or operating heavy machinery after taking the tablet.

Interaction with Other Drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional or vitamin supplements, and herbal products.

Side Effects:

• Common side effects include diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, red or itchy eyes, nail problems, hair loss, fever, blood in the urine, and burning sensation while urinating.

Additional Information:

• Store at room temperature (25°C).
• Keep out of reach from children.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.
• Monitor blood pressure regularly during treatment.
• Avoid high-fiber foods and drink lots of fluids if you have severe diarrhea.
• Antacids should not be used two hours before or one hour after taking this tablet.

FAQs:

1. What are the Tagbef 250mg tablet side effects?
   • Diarrhea, nausea, vomiting, loss of appetite, weakness, red or sore mouth, increased liver enzymes, itchy or cracked skin, dry mouth, dry, red or itchy eyes, nail problems, hair loss, fever, nosebleed, blood in the urine, and burning sensation while urinating.
2. Is Tagbef 250mg targeted therapy?
   • Yes, Tagbef 250mg Tablet is a targeted drug therapy that helps to treat advanced non-small-cell lung cancer (NSCLC).
3. Who should not use Tagbef 250mg tablets?
   • Tagbef 250mg is not indicated for children and adolescents under the age of 18. It should not be used in people who are allergic to Gefitinib, as well as pregnant or breastfeeding women.
4. Is it safe for women of reproductive potential to use Tagbef 250mg tablets?
   • Tagbef 250mg tablets are not recommended for use during pregnancy and breastfeeding. Tell your healthcare provider before starting this treatment if you are pregnant, think you might be pregnant, breastfeeding, or planning to have a baby.
5. What should I avoid while taking Tagbef 250mg tablets?
   • It is advised to avoid taking an antacid or stomach acid-reducing medication within two hours before or one hour after taking a Tagbef 250mg tablet.

Fact Box:

• Molecule name: Gefitinib
• Therapeutic class: Antineoplastics
• Pharmacological class: Tyrosine kinase inhibitors
• Indications: Non-small cell lung cancer

Tags: tagbef, tablet, medicine, 250mg